Risk of Side Effects of COMIRNATY Intramuscular Injection for 5 to 11 Years Old in Children during the Omicron Wave in Japan

Efficacy of vaccination of the COMIRNATY intramuscular injection for 5 to 11 years old Pfizer BioNTech against coronavirus infectious disease 2019 COVID 19 was high in pediatric trials conducted for the severe acute respiratory syndrome coronavirus 2 SARS CoV 2 variants before omicron wave. Among adults, estimated vaccine effectiveness of 2 BNT162b2 Pfizer BioNTech doses against symptomatic Omicron infection was reduced compared with prior variants. It has been clarified that the incidence of side effects on BNT162b2 is higher in Japanese than in other races. Therefore, we investigated the onset of side effects on the COMIRNATY intramuscular injection for 5 to 11 years old in Japanese children 5 to 11 years old by clinical research. From the results of clinical studies, it was clarified that the incidence of side effects on the COMIRNATY intramuscular injection for 5 to 11 years old in Japanese children is extremely low. Here, we describe the symptoms of side effects on the COMIRNATY intramuscular injection for 5 to 11 years old in Japanese children. Takuma Hayashi | Ikuo Konishi "Risk of Side Effects of COMIRNATY Intramuscular Injection for 5 to 11 Years Old in Children during the Omicron Wave in Japan" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-4 , June 2022, URL: https://www.ijtsrd.com/papers/ijtsrd50149.pdf Paper URL: https://www.ijtsrd.com/medicine/other/50149/risk-of-side-effects-of-comirnaty-intramuscular-injection-for-5-to-11-years-old-in-children-during-the-omicron-wave-in-japan/takuma-hayashi